Sandberg et al. found that breast cancer subtype (e.g., luminal A, B, HER2, HER2-enriched, triple-negative, etc.)can influence the timing (i.e., immediate vs. delayed) of breast reconstruction [13]. This evidence concerns the gene ERBB2 and breast carcinoma.